首页> 外文会议>Medical Applications of Lasers >Photodynamic detection and treatment of squamous cell carcinoma
【24h】

Photodynamic detection and treatment of squamous cell carcinoma

机译:鳞状细胞癌的光动力学检测和治疗

获取原文
获取原文并翻译 | 示例

摘要

Abstract: In this study the fluorescence intensity ofphotosensitizer in squamous cell tumors were quantifiedin terms of the tumor resolution rate. A He-Cd laser(442 nm - 17 mW) with a 600 $mu@m core silica fiber wasused for excitation. The same fiber was used forfluorescence acquisition and an optical multichannelanalyzer (EG&G, OMA III) was used to analyze thefluorescence. Twelve days after carcinoma inoculationfluorescence signal from the tumor and skin (1 cmradius from the tumor) at the 12, 3, 6, and 9 o'clockpositions were recorded. Benzoporphyrin Derivative(QLT, Canada - 2 mg/kg of body weight) was theninjected into the tail vein. The drug wasphotoactivated with a 690 nm modified argon pump cw-dyelaser (Medtech) operating at 140 mW/cm$+2$/ for 15mins. LIFS is capable of localizing in situ malignancyand evaluating photosensitizers for photodynamicfluorescence detection and therapy of tumors. !13
机译:摘要:本研究根据鳞癌的分辨率对光敏剂在鳞状细胞肿瘤中的荧光强度进行了定量。用具有600μm@ m石英纤芯的He-Cd激光器(442 nm-17 mW)进行激发。使用同一根光纤进行荧光采集,并使用光学多通道分析仪(EG&G,OMA III)分析荧光。癌接种后第十二天,在12、3、6和9点钟位置记录了来自肿瘤和皮肤的荧光信号(来自肿瘤的1厘米半径)。然后将苯并卟啉衍生物(加拿大QLT-2 mg / kg体重)注入尾静脉。用690 nm改性氩泵cw-dyelaser(Medtech)在140 mW / cm $ + 2 $ /的条件下操作15分钟,对药物进行光活化。 LIFS能够定位原位恶性肿瘤并评估用于光动力荧光检测和肿瘤治疗的光敏剂。 !13

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号